Inflammatory osteolysis: a conspiracy against bone
Gabriel Mbalaviele, Deborah V. Novack, Georg Schett, Steven L. Teitelbaum
Gabriel Mbalaviele, Deborah V. Novack, Georg Schett, Steven L. Teitelbaum
View: Text | PDF
Review

Inflammatory osteolysis: a conspiracy against bone

Abstract

There are many causes of inflammatory osteolysis, but regardless of etiology and cellular contexts, the osteoclast is the bone-degrading cell. Thus, the impact of inflammatory cytokines on osteoclast formation and function was among the most important discoveries advancing the treatment of focal osteolysis, leading to development of therapeutic agents that either directly block the bone-resorptive cell or do so indirectly via cytokine arrest. Despite these advances, a substantial number of patients with inflammatory arthritis remain resistant to current therapies, and even effective anti-inflammatory drugs frequently do not repair damaged bone. Thus, insights into events such as those impacted by inflammasomes, which signal through cytokine-dependent and -independent mechanisms, are needed to optimize treatment of inflammatory osteolysis.

Authors

Gabriel Mbalaviele, Deborah V. Novack, Georg Schett, Steven L. Teitelbaum

×

Figure 1

Cytokines are key regulators of inflammatory osteolysis.

Options: View larger image (or click on image) Download as PowerPoint
Cytokines are key regulators of inflammatory osteolysis. Despite differe...
Despite differences in the pathogenesis of various inflammatory diseases, proximal regulators of osteoclastogenesis are the same, although the “cocktail” of these factors may differ. These factors may act at one or more aspects of the osteoclastogenic pathway from osteoclast generation to activation of resorption. While the homeostatic actions of pro-osteoclast factors (green) are balanced by those that are anti-osteoclast (red), pro-osteoclast factors dominate in inflammatory conditions, thereby increasing osteoclast number and enhancing the cell’s capacity to resorb bone. Some factors, such as IFN-γ, have context-dependent effects on osteoclasts (see text). HSC, hematopoietic stem cell; OC, osteoclast.